Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Third Rock Continues To Attract Investors, Closes $516M Fund

Mar 25 2013

• By Lisa LaMotta

Related Content

Lotus Tissue Repair Scores $26 Million in Series A Round

Jun 29 2011

Genentech, Constellation Enter Largest Epigenetics Tie-Up Yet

Jan 17 2012

Seeking Drugs “Hidden In Microbes,” Third Rock Launches Warp Drive Bio

Jan 10 2012

Biotech Ventures Forth: Third Rock Rolls Out $426M Fund, Relypsa Reloads

Sep 13 2010

Lilly To Buy Alnara And Its Non-Porcine Pancreatic Enzyme Replacement Therapy

Jul 02 2010

Takeda Reaffirms Oncology Goals With $8.8 Billion Millennium Acquisition

Apr 10 2008

Shire Adds To HGT Unit With Lotus Acquisition; Gets Preclinical Rare Disease Treatment

Jan 08 2013

Related Companies

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Eli Lilly and Company

Constellation Pharmaceuticals, Inc.

Roche Holding AG

Genentech, Inc.

Warp Drive Bio, Inc.

Sanofi

Additional Topics

United States Strategy Business Strategies Deals BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window